A final consideration is allergic reactions to the glaucoma drugs. â€œWith both Combigan and Simbrinza, the allergy rates are unknown. Brimonidine is a component of both drugs; when it was first introduced, it was associated with a 20% allergy rate.he availability of combination anti-glaucoma therapies is a boon for patients and physicians when considering that about 40% of patients with glaucoma require two or more drugs to control elevated IOP levels.